In-Stent Atherosclerosis at a Crossroads: Neoatherosclerosis … or Paleoatherosclerosis?
From Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (I.A., P.H.S.); and Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge (I.A.). yannisand@yahoo.com.
Ioannis
I
Andreou
From Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (I.A., P.H.S.); and Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge (I.A.).
Peter H
PH
Stone
D003324:Coronary Artery Disease / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D003331:Coronary Vessels / Q000378:metabolism / Q000473:pathology*; D054855:Drug-Eluting Stents; D006801:Humans; D008670:Metals; D058426:Neointima; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects* / Q000295:instrumentation*; D058226:Plaque, Atherosclerotic; D011474:Prosthesis Design; D012307:Risk Factors; D015607:Stents; D016896:Treatment Outcome
D008670:Metals
atherosclerosis; atherosclerotic plaque; in-stent restenosis; mechanisms atherosclerosis; neoatherosclerosis; stent thrombosis